antipsychotic

Treatment of Cognitive Impairment in Schizophrenia

Impairments in everyday functional outcomes are very common in people with schizophrenia and these impairments are associated with deficits in cognitive functioning. Cognitive enhancement has been proposed as a pathway to disability reduction. This pathway has been clearly defined in terms of the required clinical trials methods, with primary (cognitive) and secondary (functional) outcome measures well validated. Second generation (Newer, Atypical) antipsychotic medications have been thoroughly evaluated with their cognitive enhancement potential. Read more about this session.

Pharmacotherapy challenges in patients with first-episode psychosis

Publication year: 2012Source:Journal of Affective DisordersAmal Abdel-Baki, Clairélaine Ouellet-Plamondon, Ashok Malla

Antipsychotics in pediatric and adolescent patients: A review of comparative safety data

Publication year: 2012Source:Journal of Affective DisordersLeila Ben Amor

[Correspondence] Comparative efficacy of anti-manic drugs in acute mania

Andrea Cipriani and colleagues' network meta-analysis of drug treatments in acute mania (Oct 8, p 1306) suggests that, overall, antipsychotic drugs are more efficacious than are mood stabilisers. In deriving these results, Cipriani and colleagues included studies that used combination therapy as well as those comparing monotherapy strategies.

Co-pays for long acting antipsychotic injections

I was wondering how different facilities handle the pharmacy co-pays when patient owned decanoates, constas, & sustennas are delivered to the agency for administration by staff nurses.  Our out patient nurses administer injectables to ...

Cognitive changes following antidepressant or antipsychotic treatment in adolescents at clinical risk for psychosis

Publication year: 2012Source: Schizophrenia Research, Available online 28 February 2012Christopher R. Bowie, Danielle McLaughlin, Ricardo E. Carrión, Andrea M. Auther, Barbara A. Cornblatt

Where are Poly-Pharmacy Lines Drawn

List,   At your facility or institution where do you draw the line to require Prescribers to document awareness and rational of poly pharmacy?   Below is our current draft for P&T approval.    I ...

Impact of the CATIE trial on antipsychotic prescribing patterns at a state psychiatric facility

Publication year: 2012Source: Schizophrenia Research, Available online 23 February 2012Angela M. Koranek, Tawny L. Smith, Lisa M. Mican, Karen L. Rascati

Thoughts on Levetiracetam (Keppra) as a mood stabilizer

Greetings,   I am interested in hearing anyone’s thoughts on using levetiracetam (Keppra) as a mood stabilizer.  Specifically, our patient is a 38 yo male patient with a diagnosis of Schizoaffective disorder was recently ...

Antipsychotic prescribing in nursing homes

Warnings about an increased risk of death in patients with dementia who receive atypical antipsychotics were first issued in 2004-5, after the publication of a meta-analysis of data from placebo...

This page may contain content contributed by CPNP members or aggregated from other online sources. This content is provided as an unmoderated service to members for civil discussion and collaboration. Any opinions, conclusions, or recommendations are those of the author. If you come across any abuse or violation of the terms of use, please report the abuse.